Moreover, we even detected a lower prevalence of leiomodin-1 antibodies in persons with OAE (10%) compared to controls without epilepsy (23%), although no significant difference was detected in these groups by Western blot, a more sensitive assay in our study. The gene discussed is LMOD1; the disease is epilepsy.